Today, Friday, the European Union called on Pfizer to manufacture advanced vaccines against the mutated Omicron.
The claims come a day after the European Medicines Agency approved emergency use of Pfizer’s anti-coronavirus drug PAXLOVID.
And Pfizer revealed, on Tuesday, that its drug showed very positive results.
And Pfizer said, in a statement on its website, that the final results of testing its oral anti-coronavirus drug, on 2,246 adults registered at this stage, showed that it significantly reduces the risk of death or hospitalization by 89%.
She added that she shared this data with the US Food and Drug Administration, as part of the ongoing application for authorization to use the drug in emergency situations.
PAXLOVID is an antiviral treatment for the SARS-CoV-2 protease inhibitor. It has been developed to be given orally, so that it can be prescribed at the first sign of infection or upon first awareness of exposure, which may help patients avoid severe illness, which, if authorized or approved, could lead to hospitalization and death.